Oral anticancer drugs are an increasingly prescribed form of treatment. However, studies found that 10 percent to 20 percent of patients never received the prescription, and New York-based researchers set out to discover why.
Uncategorized
Here are five cardiology studies and findings Becker's has reported since Oct. 5:
Here are four cardiology partnerships covered by Becker's since Oct. 14:
Gallipolis, Ohio-based Holzer Center for Cancer Care has a new formal affiliation with Cleveland Clinic Cancer Center which will expand specialized cancer treatments, resources and trials for patients in southeastern Ohio, the Logan Daily News reported Oct. 20.
UC San Diego Health treated their first patient with a new urinary tract cancer treatment which can prevent the need for dialysis or a kidney transplant in the future.
Advertisement
Interventional cardiology is the last subspecialty within cardiology to not use a match system to place fellows into programs, and it's time to change that, an article by TCTMD said on Oct. 19.
Tampa (Fla.) General Heart & Vascular Institute is partnering with Recora, a technology company focused on cardiac rehabilitation, to provide a virtual cardiac recovery program to outpatients across 23 counties in Florida.
UK researchers discovered a new test for cervical cancer that's more accurate and could predict breast and ovarian cancers, The Guardian reported Oct. 19.
A global approval system for oncology therapies could reduce the number of global cancer-related deaths by 10 percent to 20 percent, according to an Oct. 18 article in Harvard Business Review.
Bridgeport, Conn.-based St. Vincent's Medical Center, a Hartford HealthCare hospital, is the first in the state to use magtrace on a woman with breast cancer.